European Central Bank: Further rate hikes seen despite softer Oil – Nordea
Nordea’s Jan von Gerich highlights that the ECB delivered a widely expected 25bp hike and is likely to continue tightening, with the next move expected in July. He argues that broadening inflation pressures mean lower energy prices alone will not ease ECB concerns. Nordea’s baseline is for rates to reach 3% via consecutive hikes, above current market pricing.
Broadening inflation keeps ECB on track
"The ECB delivered the widely expected 25bp rate hike, while further clarity on the Fed’s response is expected next week."
"We expect more hikes from the ECB, and even though uncertainties remain elevated, our baseline points to the next move already at the July meeting."
"By now, there are already plenty of signs of broadening inflation pressures, so at least as far as the ECB is concerned, the question is no longer whether there will be a monetary policy response, but how big it will be."
"Lower energy prices alone would probably not remove all the ECB’s inflation worries, which has been confirmed by several Governing Council speakers as well."
"We still think the ECB will hike rates all the way to 3% at consecutive meetings, which is clearly above the current market pricing."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash

25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals
After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.
